Lenalidomide-C3-PEG3-N3

• UNSPSC Description:

  Lenalidomide-C3-PEG3-N3 is an E3 Ligase Ligand-Linker Conjugate. Lenalidomide-C3-PEG3-N3 can be used to synthesize L18I (HY-163962)[1].

• Target Antigen:

  E3 Ligase Ligand-Linker Conjugates

• Type:

  Reference compound

• Related Pathways:

  PROTAC

• Applications:

  Cancer-programmed cell death

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/lenalidomide-c3-peg3-n3.html

• Smiles:

  [N-]=[N+]=NCCOCCOCCOCCCC1=C2CN(C(C2=CC=C1)=O)C3CCC(NC3=O)=O

• Molecular Weight:

  459.50

• References & Citations:

  [1]Zhu C, et al. PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseases. Cell Discov. 2024 Aug 6;10(1):82.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported